Diamyd Medical AB Stock Nasdaq Stockholm
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- SEK | - |
Sales 2018 | - | Sales 2019 | - | Capitalization | 1.03B 11.19B |
---|---|---|---|---|---|
Net income 2018 | 25M 272M | Net income 2019 | 77M 839M | EV / Sales 2018 | - |
Net cash position 2018 | 253M 2.76B | Net cash position 2019 | 83.08M 905M | EV / Sales 2019 | - |
P/E ratio 2018 |
28.3
x | P/E ratio 2019 |
13.3
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 68.13% |
1st Jan change | Capi. | |
---|---|---|
+0.51% | 43.84B | |
+5.46% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.39% | 25.53B | |
-24.49% | 18.18B | |
-3.64% | 12.29B | |
+25.85% | 12.29B | |
+6.64% | 11.15B |